12:00 AM
 | 
Jun 14, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Veliparib: Preliminary Phase I data

Preliminary data from 18 patients in an ongoing Phase I trial showed that veliparib produced 1 partial response and 4 cases of stable disease for >8 weeks. A DLT of...

Read the full 129 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >